These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

248 related articles for article (PubMed ID: 26517688)

  • 1. Tetracycline-inducible shRNA targeting long non-coding RNA PVT1 inhibits cell growth and induces apoptosis in bladder cancer cells.
    Zhuang C; Li J; Liu Y; Chen M; Yuan J; Fu X; Zhan Y; Liu L; Lin J; Zhou Q; Xu W; Zhao G; Cai Z; Huang W
    Oncotarget; 2015 Dec; 6(38):41194-203. PubMed ID: 26517688
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Tetracycline-inducible shRNA targeting antisense long non-coding RNA HIF1A-AS2 represses the malignant phenotypes of bladder cancer.
    Chen M; Zhuang C; Liu Y; Li J; Dai F; Xia M; Zhan Y; Lin J; Chen Z; He A; Xu W; Zhao G; Guo Y; Cai Z; Huang W
    Cancer Lett; 2016 Jun; 376(1):155-64. PubMed ID: 27018306
    [TBL] [Abstract][Full Text] [Related]  

  • 3. shRNA targeting long non-coding RNA CCAT2 controlled by tetracycline-inducible system inhibits progression of bladder cancer cells.
    Li J; Zhuang C; Liu Y; Chen M; Zhou Q; Chen Z; He A; Zhao G; Guo Y; Wu H; Cai Z; Huang W
    Oncotarget; 2016 May; 7(20):28989-97. PubMed ID: 27015551
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Synthetic tetracycline-controllable shRNA targeting long non-coding RNA HOXD-AS1 inhibits the progression of bladder cancer.
    Li J; Zhuang C; Liu Y; Chen M; Chen Y; Chen Z; He A; Lin J; Zhan Y; Liu L; Xu W; Zhao G; Guo Y; Wu H; Cai Z; Huang W
    J Exp Clin Cancer Res; 2016 Jun; 35(1):99. PubMed ID: 27328915
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Tetracycline-controllable artificial microRNA-HOTAIR + EZH2 suppressed the progression of bladder cancer cells.
    Chen Y; Xie H; Zou Y; Lai X; Ma L; Liu Y; Li J
    Mol Biosyst; 2017 Jul; 13(8):1597-1607. PubMed ID: 28671703
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inducing cell growth arrest and apoptosis by silencing long non-coding RNA PCAT-1 in human bladder cancer.
    Liu L; Liu Y; Zhuang C; Xu W; Fu X; Lv Z; Wu H; Mou L; Zhao G; Cai Z; Huang W
    Tumour Biol; 2015 Sep; 36(10):7685-9. PubMed ID: 25934337
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The expression pattern of long non-coding RNA PVT1 in tumor tissues and in extracellular vesicles of colorectal cancer correlates with cancer progression.
    Guo K; Yao J; Yu Q; Li Z; Huang H; Cheng J; Wang Z; Zhu Y
    Tumour Biol; 2017 Apr; 39(4):1010428317699122. PubMed ID: 28381186
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Increased expression of ZEB1-AS1 correlates with higher histopathological grade and promotes tumorigenesis in bladder cancer.
    Lin J; Zhan Y; Liu Y; Chen Z; Liang J; Li W; He A; Zhou L; Mei H; Wang F; Huang W
    Oncotarget; 2017 Apr; 8(15):24202-24212. PubMed ID: 28445936
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Long noncoding RNA PVT1 indicates a poor prognosis of gastric cancer and promotes cell proliferation through epigenetically regulating p15 and p16.
    Kong R; Zhang EB; Yin DD; You LH; Xu TP; Chen WM; Xia R; Wan L; Sun M; Wang ZX; De W; Zhang ZH
    Mol Cancer; 2015 Apr; 14():82. PubMed ID: 25890171
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Increased expression of long non-coding RNA CCEPR is associated with poor prognosis and promotes tumorigenesis in urothelial bladder carcinoma.
    Zhan Y; Li Y; Guan B; Chen X; Chen Z; He A; He S; Gong Y; Peng D; Liu Y; Cai Z; Li X; Zhou L
    Oncotarget; 2017 Jul; 8(27):44326-44334. PubMed ID: 28574830
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The long noncoding RNA PVT1 functions as a competing endogenous RNA by sponging miR-186 in gastric cancer.
    Huang T; Liu HW; Chen JQ; Wang SH; Hao LQ; Liu M; Wang B
    Biomed Pharmacother; 2017 Apr; 88():302-308. PubMed ID: 28122299
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Knockdown of a novel lincRNA AATBC suppresses proliferation and induces apoptosis in bladder cancer.
    Zhao F; Lin T; He W; Han J; Zhu D; Hu K; Li W; Zheng Z; Huang J; Xie W
    Oncotarget; 2015 Jan; 6(2):1064-78. PubMed ID: 25473900
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Increased expression of the lncRNA PVT1 promotes tumorigenesis in non-small cell lung cancer.
    Yang YR; Zang SZ; Zhong CL; Li YX; Zhao SS; Feng XJ
    Int J Clin Exp Pathol; 2014; 7(10):6929-35. PubMed ID: 25400777
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Synthetic Tet-inducible small hairpin RNAs targeting hTERT or Bcl-2 inhibit malignant phenotypes of bladder cancer T24 and 5637 cells.
    Lin J; Liu Y; Zhan Y; Zhuang C; Liu L; Fu X; Xu W; Li J; Chen M; Cai Z; Huang W
    Tumour Biol; 2016 Mar; 37(3):3115-21. PubMed ID: 26427661
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Overexpression of CRNDE promotes the progression of bladder cancer.
    Cheng J; Chen J; Zhang X; Mei H; Wang F; Cai Z
    Biomed Pharmacother; 2018 Mar; 99():638-644. PubMed ID: 29710461
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Overexpression of long non-coding RNA TUG1 predicts poor prognosis and promotes cancer cell proliferation and migration in high-grade muscle-invasive bladder cancer.
    Iliev R; Kleinova R; Juracek J; Dolezel J; Ozanova Z; Fedorko M; Pacik D; Svoboda M; Stanik M; Slaby O
    Tumour Biol; 2016 Oct; 37(10):13385-13390. PubMed ID: 27460088
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Knockdown of long non-coding RNA plasmacytoma variant translocation 1 inhibits cell proliferation while promotes cell apoptosis via regulating miR-486-mediated CDK4 and BCAS2 in multiple myeloma.
    Zhang M; Zhao X; Cai X; Wang P; Yu M; Wei Z
    Ir J Med Sci; 2020 Aug; 189(3):825-834. PubMed ID: 31900844
    [TBL] [Abstract][Full Text] [Related]  

  • 18. LncRNA PVT1 predicts prognosis and regulates tumor growth in prostate cancer.
    Yang J; Li C; Mudd A; Gu X
    Biosci Biotechnol Biochem; 2017 Dec; 81(12):2301-2306. PubMed ID: 29050519
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Long noncoding RNA in prostate, bladder, and kidney cancer.
    Martens-Uzunova ES; Böttcher R; Croce CM; Jenster G; Visakorpi T; Calin GA
    Eur Urol; 2014 Jun; 65(6):1140-51. PubMed ID: 24373479
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Overexpression of long non-coding RNA PVT1 in gastric cancer cells promotes the development of multidrug resistance.
    Zhang XW; Bu P; Liu L; Zhang XZ; Li J
    Biochem Biophys Res Commun; 2015 Jul; 462(3):227-32. PubMed ID: 25956062
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.